The effect of a fibrin sealant on knee function after total knee replacement surgery. Results from the FIRST trial. A multicenter randomized controlled trial
- PMID: 30044846
- PMCID: PMC6059473
- DOI: 10.1371/journal.pone.0200804
The effect of a fibrin sealant on knee function after total knee replacement surgery. Results from the FIRST trial. A multicenter randomized controlled trial
Abstract
Background: Total knee replacement (TKR) is increasingly performed in short term hospital stay, making same day mobilization an important issue is after surgery. This implies little joint effusion by reducing intra-articular blood loss, which will enhance knee range of motion. The application of a topical fibrin sealant on the intraoperative bare bone and synovial tissue may contribute to better early full mobilization and thus improved functional outcomes. Since ambulation with a fully extended knee is less strenuous, we hypothesized that patients who received fibrin sealant would demonstrate improved early knee extension after six weeks compared to patients who received standard care.
Methods: A multicenter randomized controlled trial in a consecutive series of osteoarthritis patients scheduled for TKR surgery. Participants were randomized to receive fibrin sealant or not before closing the knee joint capsule. Primary outcome was change in knee extension angle(°) at short term (2 weeks) follow-up (cExt). Secondary outcomes were 6-week extension angle, knee flexion angle, hemoglobin loss, blood transfusion rates, complication rates, the Knee Society Score, and the KOOS and EQ5D questionnaires.
Results: When data on primary outcome became available from 250 patients, an interim analysis was performed by an independent Data Safety Monitoring Board for safety and effectivity assessment. This analysis showed that sufficient patients were included to detect a cExt of 10° between both groups. Inclusion was stopped however, all in the meantime included patients were treated according to their randomization. A total of 466 were available for analysis. Both groups were comparable in terms of baseline characteristics. The estimated mean cExt difference was 0.2° (95%CI -0.5 to 0.9). No differences in secondary outcomes were found.
Conclusions: No beneficial effects or side effects were found of a topically applied fibrin sealant during TKR surgery. These results discourage the clinical use of a fibrin sealant in TKR.
Trial registration: Dutch Trial Register, NTR2500.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Topical use of topical fibrin sealant can reduce the need for transfusion, total blood loss and the volume of drainage in total knee and hip arthroplasty: A systematic review and meta-analysis of 1489 patients.Int J Surg. 2016 Dec;36(Pt A):127-137. doi: 10.1016/j.ijsu.2016.10.022. Epub 2016 Oct 20. Int J Surg. 2016. PMID: 27773860 Review.
-
Determination of the efficacy of EVICEL™ on blood loss in orthopaedic surgery after total knee replacement: study protocol for a randomised controlled trial.Trials. 2015 Jul 11;16:299. doi: 10.1186/s13063-015-0822-y. Trials. 2015. PMID: 26162825 Free PMC article. Clinical Trial.
-
The efficacy of fibrin sealant in knee surgery: A meta-analysis.Orthop Traumatol Surg Res. 2015 May;101(3):331-9. doi: 10.1016/j.otsr.2014.07.035. Epub 2015 Jan 7. Orthop Traumatol Surg Res. 2015. PMID: 25577600 Review.
-
Does fibrin sealant use in total knee replacement reduce transfusion rates? A non-randomised comparative study.Orthop Traumatol Surg Res. 2012 Apr;98(2):180-5. doi: 10.1016/j.otsr.2011.10.012. Epub 2012 Mar 8. Orthop Traumatol Surg Res. 2012. PMID: 22405589 Clinical Trial.
-
Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis.Knee Surg Sports Traumatol Arthrosc. 2007 Jul;15(7):888-94. doi: 10.1007/s00167-007-0296-x. Epub 2007 Feb 24. Knee Surg Sports Traumatol Arthrosc. 2007. PMID: 17323096 Clinical Trial.
Cited by
-
The prognostic value of COX-2 in predicting metastasis of patients with colorectal cancer: A systematic review and meta analysis.Heliyon. 2023 Oct 14;9(10):e21051. doi: 10.1016/j.heliyon.2023.e21051. eCollection 2023 Oct. Heliyon. 2023. PMID: 37876424 Free PMC article. Review.
-
Recent advances in biopolymer-based hemostatic materials.Regen Biomater. 2022 Sep 21;9:rbac063. doi: 10.1093/rb/rbac063. eCollection 2022. Regen Biomater. 2022. PMID: 36196294 Free PMC article. Review.
-
Application and outlook of topical hemostatic materials: a narrative review.Ann Transl Med. 2021 Apr;9(7):577. doi: 10.21037/atm-20-7160. Ann Transl Med. 2021. PMID: 33987275 Free PMC article. Review.
-
No differences in cost-effectiveness and short-term functional outcomes between cemented and uncemented total knee arthroplasty.BMC Musculoskelet Disord. 2020 Jul 9;21(1):448. doi: 10.1186/s12891-020-03477-x. BMC Musculoskelet Disord. 2020. PMID: 32646453 Free PMC article.
-
The clot thickens: Autologous and allogeneic fibrin sealants are mechanically equivalent in an ex vivo model of cartilage repair.PLoS One. 2019 Nov 8;14(11):e0224756. doi: 10.1371/journal.pone.0224756. eCollection 2019. PLoS One. 2019. PMID: 31703078 Free PMC article.
References
-
- Kurtz SM, Ong KL, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee surgery in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;89(4):780–5 - PubMed
-
- So-Osman C, Nelissen RG, Koopman-van Gemert AW, Kluyver E, Pöll RG, Onstenk R, et al. Patient blood management in elective total hip-and knee replacement surgery: a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive policy in erythropoietin-eligible patients. Anesthesiology 2014;120(4):839–51. 10.1097/ALN.0000000000000134 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical